BlackRock Portfolio Management LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager: BlackRock Portfolio Management LLC
Reporting Manager: BlackRock Portfolio Management LLC
Security: Stoke Therapeutics, Inc. Common Stock
Symbol: STOK
Shares outstanding: 54.3M shares
Disclosed Ownership: 2.55M shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Date filed: 7/15/2025, 05:12 PM
Date of event: Jun 30, 2025
Previous filing: Apr 15, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock Portfolio Management LLC	4.7%	2.55M	2.41M	0	Spencer Fleming	Managing Director